 Allogene's Series A funding was US$300 million, including Texas Pacific Group, University of California, Two River—and even Gilead as participants, among others.In October 2019, Allogene's initial public offering netted US$324 million and a capital valuation of US$3 billion.William Tallack

William Tallack (1831–1908) was an English prison reformer and writer.